Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

about

New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.Dabigatran reversal with idarucizumab in a patient undergoing heart transplantation: first European report.

P2860

Q38061141-F67402A4-9743-4A76-8167-66B2571477CA Q41610947-75C640DD-557D-4E93-8790-D9FAE0580E32

P2860

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

Item

http://www.wikidata.org/entity/Q35975334

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Dabigatran for stroke preventi ...... enging "real-world" questions.

@ast

Dabigatran for stroke preventi ...... enging "real-world" questions.

@en

type

Item

label

Dabigatran for stroke preventi ...... enging "real-world" questions.

@ast

Dabigatran for stroke preventi ...... enging "real-world" questions.

@en

prefLabel

Dabigatran for stroke preventi ...... enging "real-world" questions.

@ast

Dabigatran for stroke preventi ...... enging "real-world" questions.

@en

P1476

Dabigatran for stroke preventi ...... enging "real-world" questions.

@en

P2093

Francisco Crespo

http://www.w3.org/2001/XMLSchema#string

Miguel Viana-Baptista

http://www.w3.org/2001/XMLSchema#string

Paulo Bettencourt

http://www.w3.org/2001/XMLSchema#string

Rui Cernadas

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

Mortality by cause for eight regions of the world: Global Burden of Disease Study

Prediction of creatinine clearance from serum creatinine

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

P304

867121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/867121

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Ferreira

Daniel Ferreira

P577

2012-05-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225074782

http://www.w3.org/2001/XMLSchema#string

P698

22645678

http://www.w3.org/2001/XMLSchema#string

P921

dabigatran

atrial fibrillation

P932

3356980

http://www.w3.org/2001/XMLSchema#string

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

about

P2860

P2860

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging "real-world" questions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932